Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F-box protein 11 (FBXO11) is a member of the F-box protein family, characterized by an F-box domain which allows it to serve as a substrate recognition subunit of the SKP1–Cullin–F-box (SCF) E3 ubiquitin ligase complex. This protein promotes ubiquitination and proteasomal degradation of numerous regulatory proteins, including BCL6, SNAIL, CDT2, CIITA, and p53, thereby modulating processes such as cell cycle progression, immune regulation, epithelial–mesenchymal transition, tumor suppression, and hematopoietic cell fate. FBXO11 exhibits additional enzymatic activity as a protein arginine N-methyltransferase. Its dysregulation is implicated in various malignancies, neurodevelopmental disorders, immune diseases such as vitiligo, and chronic middle ear infections. FBXO11 expression can serve as a biomarker for prognosis and immune function due to its specific regulation of MHC class II expression in immune cells.
Substrate recognition for SCF ubiquitin ligase leading to ubiquitination and degradation of cell-cycle and transcription regulatory proteins such as BCL6, CDT2, SNAIL, p53, BAHD1, BLIMP1, CDC25A, and CIITA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F-box protein 11 (FBXO11).